Company also unveils premium credit program for builders, startups, and enterprises to accelerate growth

PALO ALTO, Calif., April 21, 2026 /PRNewswire/ — PaleBlueDot AI today announced the launch of PBD TokenRouter at tokenrouter.com, a new platform designed to make it easier and more affordable for organizations of every size to access and manage artificial intelligence models.

Built for business use from day one, PBD TokenRouter serves the full spectrum of builders in the AI era: builders, startups, and enterprises running mission-critical AI workloads. The platform provides a comprehensive, business-to-business solution that centralizes control over AI resources for teams scaling adoption while maintaining operational and cost discipline.

Leveraging the company’s Token Factory model and existing compute infrastructure, PBD TokenRouter expands into a full-stack intelligence solution that combines proprietary token production with an ecosystem-driven go-to-market approach. Through a single integration point, PBD TokenRouter consolidates frontier providers into a single API layer that powers any AI application with all token usage managed in one place.

“Our goal is simple: to deliver faster, better, and cheaper access to intelligence infrastructure for everyone,” said Stephen Watts, CEO of PaleBlueDot AI. “Builders shouldn’t have to re-architect their stack every time a model provider goes down or a better model ships. PBD TokenRouter handles orchestration, failover, and access management, so that builders, startups, and enterprises can focus on what they’re actually building.”

Unified AI Access with Enterprise-Grade Governance

PBD TokenRouter is designed to help organizations control and optimize AI spend while ensuring consistent performance by eliminating the need for individual account registrations, replacing fragmented workflows with streamlined administration across internal teams and projects to consolidate oversight of AI usage and costs.

Key capabilities include:

Smart Token Routing: A proprietary skill that analyzes each request and routes it to the model best suited for the task, optimizing performance and cost automatically.Multi-Channel Automatic Failover: PBD TokenRouter maintains connections across multiple upstream providers, direct model access, and PBD’s self-hosted inference cloud, enabling 99.95% uptime when any route degrades.Real-Time Cost Governance: Automated budget enforcement operates at the member, team, and department level across the full request lifecycle, replacing manual reconciliation with programmatic spend controls.Smart Caching: Intelligent request deduplication and result reuse reduce unnecessary token consumption without requiring application-level changes.

PaleBlueDot AI also unveiled its Premium Token Credit Program, which selects 100 builders, startups, and enterprises each month to receive free inference credits. The program is designed to connect PBD TokenRouter with developers, founders, and teams driving the most meaningful work in AI today. As part of the program, PBD TokenRouter will host and sponsor global hackathons, partner with organizations around the world on events and programs, and support broader AI research initiatives.

PBD TokenRouter is available now at tokenrouter.com.

Contact:
palebluedotAI@fgsglobal.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/palebluedot-ai-launches-pbd-tokenrouter-a-unified-platform-for-accessing-ai-models-302749017.html

SOURCE PaleBlueDot AI

Coretelligent and the New England Venture Capital Association have announced a new partnership focused on delivering executive education, thought leadership, and curated programming for the New England venture community around security, cybersecurity, AI, governance, and compliance. The partnership is designed to strengthen NEVCA’s leadership voice while giving members practical insight they can apply to real operating and risk challenges.

NEEDHAM, Mass., April 21, 2026 /PRNewswire-PRWeb/ — Coretelligent, an award-winning provider of managed IT, cybersecurity, governance, and AI services, today announced a new partnership with the New England Venture Capital Association (NEVCA) focused on delivering executive education, thought leadership, and practical insight to the region’s venture capital community.

Through the partnership, Coretelligent and NEVCA will collaborate on content, conversations, and curated programming to help venture firms better navigate the growing operational demands in security, cybersecurity, AI, governance, and compliance. The effort is intended to strengthen NEVCA’s position as a leading voice in the market while providing members with timely, relevant guidance on issues that increasingly affect trust, resilience, and business performance.

Planned initiatives may include executive breakfasts, lunch-and-learns, member dinners, in-person educational events, and newsletter content that bring these topics to life in practical ways for the New England venture ecosystem.

“Venture firms are operating in a more complex environment, with greater pressure around cybersecurity, AI, governance, and risk,” said Ben Niernberg, Chief Revenue Officer at Coretelligent. “We are excited to partner with NEVCA to help deliver meaningful education and practical insight to the community. This partnership is about strengthening NEVCA’s role as a thought leader while giving members access to conversations and guidance that can help them make smarter decisions and build stronger operating discipline.”

As firms face rising expectations from investors, portfolio companies, regulators, and internal stakeholders, the need for sharper visibility and stronger governance continues to grow. Coretelligent and NEVCA see an opportunity to create programming and content that helps venture leaders address those challenges with greater confidence and clarity.

“NEVCA exists to support and strengthen the New England innovation economy by connecting our community with the ideas, resources, and relationships that matter most,” said Hope Hopkins, Executive Director of NEVCA. “Coretelligent brings valuable expertise across cybersecurity, AI, governance, and operational risk. We are excited to partner with them to expand the education and thought leadership available to our members and to continue elevating the conversations shaping the future of the venture ecosystem.”

The partnership reflects a shared commitment to helping the venture community stay informed, prepared, and better equipped to navigate a changing operating environment.

About Coretelligent

Coretelligent is an award-winning provider of managed IT, cybersecurity, governance, and AI services for small and mid-sized, highly regulated and growing businesses. The company helps organizations strengthen operations, reduce risk, and navigate technology complexity through strategic guidance, responsive support, and deep domain expertise. For more information, visit www.coretelligent.com.

About NEVCA

The New England Venture Capital Association (NEVCA) supports the region’s venture ecosystem by connecting investors, founders, and industry leaders through programming, advocacy, resources, and community-building initiatives. For more information, visit NEVCA.

Media Contact

Paul Zonis, Coretelligent, 1 855-841-5888, marketing@core.tech, coretelligent.com

View original content to download multimedia:https://www.prweb.com/releases/coretelligent-and-nevca-announce-partnership-to-expand-executive-education-and-thought-leadership-for-the-new-england-venture-community-302748965.html

SOURCE Coretelligent

SAN FRANCISCO and PORTLAND, Ore. and BOSTON, April 21, 2026 /PRNewswire/ — Drug Hunter, the intelligence platform for drug discovery teams, today announced the launch of Molecule Search, a significant upgrade to its structure search experience. The update allows researchers to run parallel searches across FDA-Approved Drugs, Modern Clinical Compounds, Recent Disclosures, and Drug Hunter indexed molecules simultaneously, reducing the time and effort required to move from a structural query to a meaningful insight.

Structure-based research has long required scientists to navigate multiple tools and disconnected databases. This release consolidates those workflows into a single, more intuitive experience as the platform now pairs chemical matter with biological context, including indexed targets, mechanisms of action, 3D structure information, and therapeutic areas, without requiring users to leave the platform.

“Scientists increasingly need to explore chemical and biological data together,” said Dennis Hu, Ph.D., Founder and CEO of Drug Hunter. “This update brings discovery teams a ‘one-stop shop’ for the key chemical and biological data needed to contextualize industry precedents.” “

The Molecule Search update introduces several connected capabilities:

Parallel structure search across Drug Hunter Molecules, FDA-Approved Drugs, and Modern Clinical Compounds with 2D molecular property refinementBiological context for chemical matter, with disclosures indexed by drug target or pathogen and mechanism of actionReferenceable compound & protein structural data within search resultsVisual landscape tools to overlay approved drugs, clinical compounds, and disclosures in chemical space, or isolate a dataset for deeper analysis

“Scientists rarely lack access to data. This is becoming even more of an issue as AI-based tools expand the net wider than ever. The problem is connecting it,” said John Overington, Ph.D., Chief Data Officer at Drug Hunter. “Molecule Search brings chemical structure and biological context into the same query, so researchers spend less time assembling a picture and more time understanding it.”

Molecule Search is available now to all Drug Hunter members. Researchers and R&D teams interested in accessing the platform can request a personalized demo at www.drughunter.com/.

About Drug Hunter

Drug Hunter is a scientist-built intelligence platform that helps drug discovery organizations rapidly act on insights from the rest of the industry. By analyzing and distilling actionable precedents from thousands of industry sources into a searchable, structured platform, Drug Hunter gives drug discovery teams the chemical and biological lessons they need to make confident, strategic decisions. Founded and operated by industry scientists, Drug Hunter is trusted by more than 200 biotech and pharma organizations worldwide.

Website: www.drughunter.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/drug-hunter-launches-molecule-search-a-unified-structure-search-experience-across-chemical-and-biological-data-302748985.html

SOURCE Drug Hunter